Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction: A randomized, placebo-controlled, double-blind study (RUSSLAN)
Moiseyev V.S.,
Põder P.,
Andrejevs N.,
Ruda M.Y.,
Golikov A.P.,
Lazebnik L.B.,
Kobalava Z.D.,
Lehtonen L.A.,
Laine T.,
Nieminen M.S.,
Lie K.I.
Связанные документы (рекомендация CORE)